Literature DB >> 12722795

Expression of C-ERBB2 and P65 genes and their protein products in follicular neoplasms of thyroid gland.

W Czyz1, E Balcerczak, M Rudowicz, H Niewiadomska, Z Pasieka, K Kuzdak, M Mirowski.   

Abstract

C-ERBB2 and P65 gene expression was investigated by reverse transcriptase polymerase chain reaction method (RT-PCR) in thirty follicular thyroid cancers and twenty follicular adenomas. Additionally, the cancers and adenomas were stained by immunohistochemistry for the expression of their protein products. We did not observe P65 gene expression in any of the analyzed follicular cancers (n=30) but it was observed in 13 out of 20 (65%) follicular adenomas. The presence of C-ERBB2 gene expression was found in 18 (90%) follicular adenomas but not in cancers. There were 10 (50%) adenomas and 11 (36.7%) cancers with positive staining for C-ERBB2 protein and 15 (75%) adenomas and 2 (6.7%) cancers with positive staining for P65 protein. We conclude that expression of C-ERBB2 and P65 genes is associated with follicular adenoma but not with cancer of thyroid gland.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12722795

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  2 in total

1.  Investigation of FJ 194940.1 gene alternative splicing in colon cancer and its association with clinicopathological parameters.

Authors:  Malwina Bartczak-Tomczyk; Aleksandra Sałagacka; Marek Mirowski; Ewa Balcerczak
Journal:  Exp Ther Med       Date:  2011-11-09       Impact factor: 2.447

2.  Quantitative analysis of FJ 194940.1 gene expression in colon cancer and its association with clinicopathological parameters.

Authors:  Malwina Bartczak-Tomczyk; Aleksandra Sałagacka; Marek Mirowski; Agnieszka Jeleń; Ewa Balcerczak
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.